Novel mRNA vaccine GLB-COV2-043 shows high efficacy against COVID-19 variants in early trials Post author: Post published:December 5, 2023 Post category:uncategorized The safety, efficacy, and immunogenicity of a mRNA-based vaccine. You Might Also Like Novel antibiotic shows activity against WHO high priority pathogen VRE October 27, 2025 Balancing health and economy: A new model to assess pandemic response strategies November 23, 2023 NeuMap unveils the hidden architecture and life-long patterns of human neutrophils December 3, 2025